Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tropifexor in Primary Biliary Cholangitis
NCT02516605Phase 2Completed
- Sponsor
- Novartis
- Start
- Sep 2015
- Primary completion
- Aug 2018
- Modality
- Small Molecules
- Countries
- 6
01
Overview
A Phase 2 trial of tropifexor in primary biliary cholangitis (PBC), sponsored by Novartis. Started Sep 2015; status: completed.
02
Drugs
tropifexor
03
Conditions
primary biliary cholangitis (PBC)
Beyond the preview
Go deeper on NCT02516605.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02516605.